MAPT and Alzheimer disease: Macrostructural volumetric reductions observed via magnetic resonance imaging (MRI) reflect neurodegeneration as a key feature within the Amyloid-Tau-Neurodegeneration (ATN) framework of Alzheimer’s disease (AD) pathogenesis [1, 2].